August 28, 2016 10:27 AM ET


Company Overview of FORMA Therapeutics, Inc.

Key Executives for FORMA Therapeutics, Inc.

NameBoard RelationshipsTitleAge
Steven Tregay Ph.D.11 RelationshipsCo-Founder, Chief Executive Officer, President and Director--
Michael A. Foley Ph.D.11 RelationshipsCo-Founder and Director--
Helen M. Boudreau 17 RelationshipsChief Financial Officer50
Dennis France No RelationshipsHead of Biomolecular Screening and Executive Director--
John Hohneker M.D.No RelationshipsHead of Research & Development and Executive Vice President--
View More Key Executives

FORMA Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Peter Wirth Esq., J.D. 25 RelationshipsLysosomal Therapeutics Inc.66
Steven Tregay Ph.D. 11 RelationshipsFORMA Therapeutics, Inc.--
Michael A. Foley Ph.D. 11 RelationshipsFORMA Therapeutics, Inc.--
Marsha H. Fanucci 75 RelationshipsMomenta Pharmaceuticals Inc.62
Paolo Paoletti M.D. 34 RelationshipsKesios Therapeutics Limited65
View All Board Members

FORMA Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Marsha H. Fanucci75 Relationships1 Executives
Management/Organization Development Committee M.D.Paolo Paoletti34 Relationships1 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Total Value of Options
Compensation as of Fiscal Year
FORMA Therapeutics, Inc. CEO Compensation
Industry Average


ProclaRx Appoints Doug Martin as New Chief Operating Officer
August 27, 2016 7:45 AM ET
Juno Therapeutics, Inc. Announces Resignation of Marc Tessier-Lavigne from the Board of Directors
August 26, 2016 9:11 PM ET
Agios Pharmaceuticals, Inc. Announces Management Changes
August 26, 2016 8:02 PM ET
Tapimmune, Inc. Appoints Michael Loiacono as Chief Financial Officer, Chief Accounting Officer, Secretary and Treasurer
August 25, 2016 12:52 PM ET
OptiBiotix Health plc Announces Executive Changes
August 25, 2016 6:00 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact FORMA Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at